Interesting comments, Clinical trials take time for approval by the FDA which often times takes years. Fortunately there are other avenues for revenue which Generex has branched into which have more immediate results. The balance sheet is improving and will gain traction especially when Generex gets off the OTC.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links